Last month, BlueRemediomics partners came together for three days in the Latvian capital to present updates and discuss the project’s progress and challenges. Hosted by

BlueRemediomics partners from the University of Aberdeen and ABS International/3BIO co-organised a workshop on Article 12 of the Agreement and served as Rapporteurs during the BBNJ Symposium in Singapore

Originally published by CORDIS.  Can seaweed help reduce inflammation in farmed fish? An EU-backed study investigates.  A recent study carried out by Norwegian and Spanish researchers explores

February 20 is World Day of Social Justice, an opportunity to show how BlueRemediomics partners are working to improve Access and Benefit-Sharing (ABS), to ensure

More than twenty researchers from across the world have come together to publish a collaborative book, ‘Decoding Marine Genetic Resource Governance Under the BBNJ Agreement’,

Return of the schooner Tara and the EMBL mobile laboratory after an unprecedented 18-month land-sea expedition On October 5th 2024, the scientific schooner Tara returned

The concept of “doing no significant harm” runs through the EU Horizon Europe project BlueRemediomics, and has been explored in the past in “Town Hall”

In time for the Sixteenth meeting of the Conference of the Parties to the Convention on Biological Diversity (COP 16) taking place from the 21st of October

BlueRemediomics researcher Professor Marcel Jaspars from the University of Aberdeen has co-authored a new article published by Nature Communications on “Harmonizing rules for digital sequence